The $8.4million project will develop technology to rapidly develop vaccines against known pathogens - such as flu, and unknown pathogens, called Disease X. The project will create a so-called self-amplifying RNA (saRNA) vaccine platform.
Public health systems must be resilient and prepared to face existing and future disease threats at the human-animal-environment interface. This Operational Framework provides a practical reference toward achieving that aim.
A One Health approach is critical to strengthening health security at country, regional, and global levels. However, operationally its uptake remains limited.
Every month, approximately 300 reports cross the desk of Dr Sylvie Briand detailing an outbreak of a disease somewhere in the world.
A new study of disease transmission in bats has broad implications for understanding hidden or "cryptic" connections that can spread diseases between species and lead to large-scale outbreaks.
Not all pandemics are caused by the obvious suspects. Though the media have us whipped up into a frenzy over a select cast of superstar pathogens, the villain in the next global drama may be lurking in the unlikeliest of places; perhaps it hasn’t even been discovered yet.
The current form of One Health movement has emerged in an unprecedented response to the highly pathogenic avian influenza, a pandemic zoonotic disease.
Globalization has increased the rate at which arthropod vectors and associated pathogens emerge and spread. A persistent challenge to the public health agencies in the United States is to identify and control emerging foreign human and animal health threats.
Earlier this year the World Health Organization (WHO) announced it was sufficiently concerned about what was lurking in the wild to include something called ‘Disease X’ in its global strategy plan, representing an as yet undiscovered pathogen with the potential to spark a pandemic.